Platelet microparticle: A sensitive physiological "fine tuning" balancing factor in health and disease

Transfusion and Apheresis Science

Volumn 52, Issue 1, 2015, Pages 12-18

  Goubran, Hadi Alphonse ^a   Burnouf, Thierry ^b   Stakiw, Julie ^a   Seghatchian, Jerard ^c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b International Consultancy in Blood Components Quality Safety Improvement   (United Kingdom)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Microparticles; Platelets; PMP

Indexed keywords

GROWTH FACTOR; MICRORNA; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT;

APOPTOSIS; BLOOD COMPONENT; BLOOD TRANSFUSION REACTION; CELL INTERACTION; COMPLEMENT ACTIVATION; CYTOSKELETON; HEMOSTASIS; MEGAKARYOCYTE; MEMBRANE FUSION; PATHOGENESIS; PLATELET MICROPARTICLE; REVIEW; SENESCENCE; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE; ANIMAL; CELL AGING; HUMAN; MEMBRANE MICROPARTICLE; METABOLISM; NEOPLASMS; PARTICLE SIZE; PATHOLOGY; THROMBOCYTE; THROMBOSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD PLATELETS; CELL AGING; CELL-DERIVED MICROPARTICLES; COMPLEMENT ACTIVATION; CYTOSKELETON; HUMANS; MEGAKARYOCYTES; NEOPLASMS; PARTICLE SIZE; PLATELET AGGREGATION INHIBITORS; THROMBOSIS;

EID: 84926208232     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2014.12.015     Document Type: Review

References (74)

1. Ellis H. James Blundell, pioneer of blood transfusion. Br J Hosp Med 2007, 68:447.
2. Blajchman M.A. Platelet transfusions: an historical perspective. Hematology Am Soc Hematol Educ Program 2008, 197.
3. Burnouf T., Goubran H.A., Chou M.-L., Devos D., Radosevic M. Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine. Blood Rev 2014, 28:155-156. 10.1016/j.blre.2014.04.002.
4. Semple J.W., Italiano J.E., Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011, 11:264-274.
5. Nomura S. Function and clinical significance of platelet-derived microparticles. Int J Hematol 2001, 74:397-404.
6. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967, 13:269-288.
7. Sims P., Wiedmer T., Esmon C.T., Weiss H., Shattil S. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989, 264:17049-17057.
8. Simak J., Gelderman M.P. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006, 20:1-26.
9. Flaumenhaft R., Dilks J.R., Richardson J., Alden E., Patel-Hett S.R., Battinelli E., et al. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood 2009, 113:1112-1121.
10. Gilbert G.E., Sims P., Wiedmer T., Furie B., Furie B., Shattil S. Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 1991, 266:17261-17268.
11. Comfurius P., Senden J.M., Tilly R.H., Schroit A.J., Bevers E.M., Zwaal R.F. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys Acta 1990, 1026:153-160.
12. Hoffman M., Monroe D., Roberts H. Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: a flow cytometric study. Thromb Haemost 1992, 68:74-78.
13. Barry O.P., Praticò D., Lawson J.A., FitzGerald G.A. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997, 99:2118.
14. Baj-Krzyworzeka M., Majka M., Pratico D., Ratajczak J., Vilaire G., Kijowski J., et al. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 2002, 30:450-459.
15. Sprague D.L., Elzey B.D., Crist S.A., Waldschmidt T.J., Jensen R.J., Ratliff T.L. Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood 2008, 111:5028-5036.
16. Wiedmer T., Shattil S.J., Cunningham M., Sims P.J. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 1990, 29:623-632.
17. Krailadsiri P., Seghatchian J., Macgregor I., Drummond O., Perrin R., Spring F., et al. The effects of leukodepletion on the generation and removal of microvesicles and prion protein in blood components. Transfusion 2006, 46:407-417.
18. Garraud O., Cognasse F., Hamzeh-Cognasse H., Laradi S., Pozzetto B., Muller J.Y. Blood transfusion and inflammation]. Transfus Clin Biol 2013, 20:231-238.
19. Krailadsiri P., Seghatchian J. Microvesicles in platelet concentrates 2000, Elsevier, Chapter 12.
20. Seghatchian J., Krailadsiri P. The platelet storage lesion. Transfus Med Rev 1997, 11:130-144.
21. Krailadsiri P., Seghatchian J., Bode A.P. Microvesicles in blood components: laboratory and clinical aspects. Clin Appl Thromb Hemost 1997, 3:86-95.
22. Italiano J.E., Mairuhu A.T., Flaumenhaft R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 2010, 17:578.
23. Zwaal R.F., Comfurius P., Bevers E.M. Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis. BBA Mol Basis Dis 1992, 1180:1-8.
24. Briedë J.J., Heemskerk J.W., Hemker H.C., Lindhout T. Heterogeneity in microparticle formation and exposure of anionic phospholipids at the plasma membrane of single adherent platelets. BBA Mol Cell Res 1999, 1451:163-172.
25. Freyssinet J.-M., Toti F. Formation of procoagulant microparticles and properties. Thromb Res 2010, 125:S46-S48.
26. Camera M., Brambilla M., Boselli D., Facchinetti L., Canzano P., Rossetti L., et al. Response: functionally active platelets do express tissue factor. Blood 2012, 119:4339-4341.
27. Osterud B., Olsen J.O. Human platelets do not express tissue factor. Thromb Res 2013, 132:112-115.
28. Kahner B., Dorsam R., Kunapuli S. Role of P2Y receptor subtypes in platelet-derived microparticle generation. Front Biosci 2008, 13:433.
29. Hill A., Kelly R.J., Hillmen P. Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood 2013, 121:4985-4996.
30. Sims P.J., Wiedmer T. Repolarization of the membrane potential of blood platelets after complement damage: evidence for a Ca++-dependent exocytotic elimination of C5b-9 pores. Blood 1986, 68:556-561.
31. Wiedmer T., Sims P. Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles. Blood 1991, 78:2880-2886.
32. Hugel B., Socié G., Vu T., Toti F., Gluckman E., Freyssinet J.-M., et al. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 1999, 93:3451-3456.
33. Schneider S., Nuschele S., Wixforth A., Gorzelanny C., Alexander-Katz A., Netz R., et al. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers. PNAS 2007, 104:7899-7903.
34. Miyazaki Y., Nomura S., Miyake T., Kagawa H., Kitada C., Taniguchi H., et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996, 88:3456-3464.
35. Holme P.A., Ørvim U., Hamers M.J., Solum N.O., Brosstad F.R., Barstad R.M., et al. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol 1997, 17:646-653.
36. Chow T.W., Hellums J.D., Thiagarajan P. Thrombin receptor activating peptide (SFLLRN) potentiates shear-induced platelet microvesiculation. J Lab Clin Med 2000, 135:66-72.
37. Iwamoto S.-I., Kawasaki T., Kambayashi J.-I., Ariyoshi H., Monden M. Platelet microparticles: a carrier of platelet-activating factor?. Biochem Biophys Res Commun 1996, 218:940-944.
38. Gyulkhandanyan A.V., Mutlu A., Freedman J., Leytin V. Markers of platelet apoptosis: methodology and applications. J Thromb Thrombolysis 2012, 33:397-411.
39. Cerecedo D. Platelet cytoskeleton and its hemostatic role. Blood Coagul Fibrinolysis 2013, 24:798-808.
40. Thon J.N., Italiano J.E. Platelets: production, morphology and ultrastructure 2012, 3-22. Springer-Verlag, Berlin Heidelberg, Antiplatelet Agents. Handbook of Experimental Pharmacology.
41. Fox J., Austin C.D., Boyles J.K., Steffen P.K. Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane. J Cell Biol 1990, 111:483-493.
42. Nomura S., Komiyama Y. [Shear stress and platelet-derived microparticles]. Rinsho Byori 1997, 45:927-933.
43. Bassé F., Gaffet P., Bienvenüe A. Correlation between inhibition of cytoskeleton proteolysis and anti-vesiculation effect of calpeptin during A23187-induced activation of human platelets: are vesicles shed by filopod fragmentation?. BBA Bioenergetics 1994, 1190:217-224.
44. Zwaal R.F., Schroit A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997, 89:1121-1132.
45. Lee Y.J., Jy W., Horstman L.L., Janania J., Reyes Y., Kelley R.E., et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res 1993, 72:295-304.
46. Willerson J.T., Golino P., Eidt J., Campbell W., Buja L. Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications. Circulation 1989, 80:198-205.
47. Lopes-Virella M.F., Virella G. Immune mechanisms of atherosclerosis in diabetes mellitus. Diabetes 1992, 41:86-91.
48. Lim M.Y., Ataga K.I., Key N.S. Hemostatic abnormalities in sickle cell disease. Curr Opin Hematol 2013, 20:472-477.
49. Goubran H.A., Stakiw J., Radosevic M., Burnouf T. Platelets effects on tumor growth. Seminars in oncology 2014, Elsevier.
50. Goubran H.A., Stakiw J., Radosevic M., Burnouf T. Platelet-cancer interactions. Seminars in thrombosis and hemostasis 2014, 296-305. Thieme Medical Publishers.
51. Piccin A., Murphy W.G., Smith O.P. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007, 21:157-171.
52. Castaman G., Yu-Feng L., Rodeghiero F. A bleeding disorder characterised by isolated deficiency of platelet microvesicle generation. Lancet 1996, 347:700-701.
53. Reid V., Webster N. Role of microparticles in sepsis. Br J Anaesth 2012, 109:503-513.
54. Nurden A., Nurden P., Sanchez M., Andia I., Anitua E. Platelets and wound healing. Front Biosci 2008, 13:3532.
55. Burnouf T., Goubran H.A., Chen T.-M., Ou K.-L., El-Ekiaby M., Radosevic M. Blood-derived biomaterials and platelet growth factors in regenerative medicine. Blood Rev 2013, 27:77-89.
56. Freyssinet J.M. Cellular microparticles: what are they bad or good for?. J Thromb Haemost 2003, 1:1655-1662.
57. Siljander P.R. Platelet-derived microparticles-an updated perspective. Thromb Res 2011, 127:S30-S33.
58. Torreggiani E., Perut F., Roncuzzi L., Zini N., Baglio S.R., Baldini N. Exosomes: novel effectors of human platelet lysate activity. Eur Cells Mater 2014, 28:137-151. discussion 51.
59. Goubran H.A., Burnouf T., Radosevic M., El-Ekiaby M. The platelet-cancer loop. Eur J Intern Med 2013, 24:393-400.
60. Kim H.K., Song K.S., Chung J.H., Lee K.R., Lee S.N. Platelet microparticles induce angiogenesis in vitro. Br J Haematol 2004, 124:376-384.
61. Goubran H.A., Kotb R.R., Stakiw J., Emara M.E., Burnouf T. Regulation of tumor growth and metastasis: the role of tumor microenvironment. Cancer Growth Metastasis 2014, 7:9.
62. Mezouar S., Mege D., Darbousset R., Farge D., Debourdeau P., Dignat-George F., et al. Involvement of platelet-derived microparticles in tumor progression and thrombosis. Seminars in oncology 2014, Elsevier.
63. Rak J. Microparticles in cancer. Seminars in thrombosis and hemostasis 2010, 888-906. © Thieme Medical Publishers.
64. Kim H., Song K., Park Y., Kang Y., Lee Y., Lee K., et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 2003, 39:184-191.
65. Helley D., Banu E., Bouziane A., Banu A., Scotte F., Fischer A.-M., et al. Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy. Eur Urol 2009, 56:479-485.
66. Varon D., Shai E. Role of platelet-derived microparticles in angiogenesis and tumor progression. Discov Med 2009, 8:237-241.
67. Shantsila E., Kamphuisen P., Lip G. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost 2010, 8:2358-2368.
68. Østerud B. The role of platelets in decrypting monocyte tissue factor. Dis Mon 2003, 49:7-13.
69. Ayers L., Kohler M., Harrison P., Sargent I., Dragovic R., Schaap M., et al. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay. Thromb Res 2011, 127:370-377.
70. Artoni A., Merati G., Padovan L., Scalambrino E., Chantarangkul V., Tripodi A. Residual platelets are the main determinants of microparticles count in frozen-thawed plasma. Thromb Res 2012, 130:561-562.
71. Lacroix R., Judicone C., Poncelet P., Robert S., Arnaud L., Sampol J., et al. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost 2012, 10:437-446.
72. Abrams C.S., Ellison N., Budzynski A., Shattil S. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990, 75:128-138.
73. Mobarrez F., Nybom R., Johansson V., Hultman C.M., Wallén H., Landén M., et al. Microparticles and microscopic structures in three fractions of fresh cerebrospinal fluid in schizophrenia: case report of twins. Schizophr Res 2013, 143:192-197.
74. Parot P., Dufrêne Y.F., Hinterdorfer P., Le Grimellec C., Navajas D., Pellequer J.L., et al. Past, present and future of atomic force microscopy in life sciences and medicine. J Mol Recognit 2007, 20:418-431.